Axxion S.A.’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$373K Sell
1,650
-550
-25% -$117K 0.02% 268
2026
Q2
$475K Buy
+2,200
New +$421K 0.03% 230

Other funds holding BIIB

Axxion S.A.'s BIIB Position: Q3 2026 in Review

Axxion S.A. reduced its Biogen (BIIB) stake by 25% in Q3 2026, selling an estimated $117K and leaving 1,650 shares worth $373K. The position accounts for 0.02% of the portfolio, ranked #268.

Axxion S.A. first reported a position in BIIB in Q2 2026 and has held it in 2 quarters since. The position peaked at $475K in Q2 2026. 1,057 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Axxion S.A. held 1,650 shares of Biogen worth $373K as of Q3 2026.
  • Axxion S.A. sold 550 Biogen shares in Q3 2026, an estimated $117K.
  • Biogen made up 0.02% of Axxion S.A.'s portfolio in Q3 2026, its #268 holding.
  • Axxion S.A. first reported a position in Biogen in Q2 2026 and has held it in 2 quarters since.
  • Axxion S.A.'s Biogen position peaked at $475K in Q2 2026.
  • 1,057 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Axxion S.A.'s 13F filing for Q3 2026, filed 22 Oct 2026.